Insider · CIK 0001276038

SANTINI GINO

Reports to the SEC for 8 companies · STOUGHTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001276038

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+8,700 sh	$16.49	+$143K	112,483
2026-06-08	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−8,700 sh	—	—	0
2026-05-27	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+30.2K sh	—	—	30,158
2026-05-14	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+8,741 sh	—	—	103,783
2025-08-15	COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$13.45	+$202K	100,447
2025-08-15	COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale	Director	SSale	−5,405 sh	$37.19	−$201K	95,042
2025-08-15	COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2025-06-12	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+39K sh	—	—	39,000
2025-05-15	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,791 sh	—	—	85,447
2024-09-03	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+52K sh	—	—	52,000
2024-05-16	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+7,693 sh	—	—	75,656
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.U Disposition from Tender	Director	UDisposition from Tender	−23.6K sh	$19.00	−$449K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,111 sh	$19.00	−$154K	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−1,598 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,036 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,748 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,174 sh	—	—	0
2023-11-08	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,966 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	$116.50	−$11.8M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−18.7K sh	$116.50	−$2.17M	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,548 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-10-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+23.1K sh	$15.23	+$352K	100,959
2023-10-02	Horizon Therapeutics Public Ltd CoStock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−23.1K sh	—	—	0
2023-09-22	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$15.96	+$319K	77,867
2023-09-22	Horizon Therapeutics Public Ltd CoStock Option (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-05-24	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+8,111 sh	—	—	31,756
2023-05-24	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.5K sh	—	—	12,547
2023-05-18	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,792 sh	—	—	67,963
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	57,867
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2022-05-25	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+7,737 sh	—	—	23,645
2022-05-25	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.8K sh	—	—	12,790
2022-05-19	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+14K sh	—	—	58,171
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	50,472
2022-04-29	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,658 sh	$98.56	−$163K	48,814
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-06-03	Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+37K sh	—	—	37,000
2021-05-27	INTERCEPT PHARMACEUTICALS, INC.A Award	Director	AAward	+7,029 sh	—	—	15,908
2021-05-27	INTERCEPT PHARMACEUTICALS, INC.Option to Purchase Common StockA Award	Director	AAward	+12.1K sh	—	—	12,089
2021-05-20	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+9,941 sh	—	—	44,136
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	50,606

Recent filings

Accepted (ET)
Jun 104
SANTINI GINO0001276038-26-000006
SEC(opens sec.gov)
May 294
SANTINI GINO0001276038-26-000004
SEC(opens sec.gov)
May 184
SANTINI GINO0001276038-26-000002
SEC(opens sec.gov)
Aug 194
SANTINI GINO0001062993-25-014694
SEC(opens sec.gov)
Jun 134
SANTINI GINO0001816590-25-000083
SEC(opens sec.gov)
May 194
SANTINI GINO0001062993-25-009805
SEC(opens sec.gov)
Sep 44
SANTINI GINO0001628280-24-039398
SEC(opens sec.gov)
May 164
SANTINI GINO0001062993-24-010543
SEC(opens sec.gov)
Nov 134
SANTINI GINO0001104659-23-117106
SEC(opens sec.gov)

Companies

Address

C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE

STOUGHTON, MA, 02072